News
New Acute Myeloid Leukemia Data In the NCI Proteomic Data Commons
On June 24, the NCI Proteomics Data Commons released 700 files from the Clinical Proteomic Tumor Analysis Consortium study investigating the microenvironment of Acute Myeloid Leukemia (AML) and how it catalyzes gilteritinib resistance.
Totaling more than 100 GB of data, the release is grouped into 6 studies that can be accessed directly from the PDC’s data portal:
- AML Gilteritinib Resistance - Proteome: (PDC000315)
- AML Gilteritinib TimeCourse - Proteome: (PDC000316)
- AML Quizartinib Resistance - Proteome: (PDC000317)
- AML Gilteritinib Resistance - Phosphoproteome: (PDC000318)
- AML Gilteritinib TimeCourse - Phosphoproteome: (PDC000319)
- AML Quizartinib Resistance - Phosphoproteome: (PDC000320)
In addition, accompanying genomics data from this multiomics study can be accessed through the PDC (under external references). For more details on the insights CPTAC investigators learned from this comprehensive proteogenomics research, read their recent publication in Cancer Cell.
As a component of the Cancer Research Data Commons, the PDC connects researchers with large-scale proteomics data and the high-performance computational tools to analyze that data. For more information on the data and tools you can find in the PDC, visit the Data Commons website.